Doximity Inc (NYSE: DOCS) has experienced a decline in its stock price by -1.83 compared to its previous closing price of 58.54. However, the company has seen a gain of 5.31% in its stock price over the last five trading days. zacks.com reported 2025-06-11 that Doximity strengthens client loyalty by embedding AI tools and clinical workflows into its platform for medical professionals.
Is It Worth Investing in Doximity Inc (NYSE: DOCS) Right Now?
Doximity Inc (NYSE: DOCS) has a higher price-to-earnings ratio of 51.89x compared to its average ratio, The 36-month beta value for DOCS is at 1.34. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 3 rating it as “overweight,” 11 as “hold,” and 0 as “sell.”
The public float for DOCS is 132.76M, and currently, shorts hold a 3.69% of that float. The average trading volume for DOCS on June 12, 2025 was 2.65M shares.
DOCS’s Market Performance
DOCS stock saw a decrease of 5.31% in the past week, with a monthly decline of -5.85% and a quarterly a decrease of -10.62%. The volatility ratio for the week is 2.05%, and the volatility levels for the last 30 days are 3.30% for Doximity Inc (DOCS). The simple moving average for the past 20 days is 5.65% for DOCS’s stock, with a 7.55% simple moving average for the past 200 days.
Analysts’ Opinion of DOCS
Many brokerage firms have already submitted their reports for DOCS stocks, with BTIG Research repeating the rating for DOCS by listing it as a “Buy.” The predicted price for DOCS in the upcoming period, according to BTIG Research is $80 based on the research report published on June 02, 2025 of the current year 2025.
Piper Sandler, on the other hand, stated in their research note that they expect to see DOCS reach a price target of $78, previously predicting the price at $31. The rating they have provided for DOCS stocks is “Overweight” according to the report published on February 07th, 2025.
Leerink Partners gave a rating of “Outperform” to DOCS, setting the target price at $90 in the report published on February 07th of the current year.
DOCS Trading at 4.20% from the 50-Day Moving Average
After a stumble in the market that brought DOCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.55% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at DOCS starting from Wampler Kira Scherer, who sale 2,000 shares at the price of $52.89 back on Jun 02 ’25. After this action, Wampler Kira Scherer now owns 16,618 shares of Doximity Inc, valued at $105,780 using the latest closing price.
KIRA WAMPLER, the Director of Doximity Inc, proposed sale 2,000 shares at $52.89 during a trade that took place back on Jun 02 ’25, which means that KIRA WAMPLER is holding shares at $105,780 based on the most recent closing price.
Stock Fundamentals for DOCS
Current profitability levels for the company are sitting at:
- 0.4 for the present operating margin
- 0.9 for the gross margin
The net margin for Doximity Inc stands at 0.39. The total capital return value is set at 0.21. Equity return is now at value 22.50, with 18.93 for asset returns.
Based on Doximity Inc (DOCS), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 22.04.
Currently, EBITDA for the company is 227.8 million with net debt to EBITDA at -0.85. When we switch over and look at the enterprise to sales, we see a ratio of 18.58. The receivables turnover for the company is 4.44for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.92.
Conclusion
In conclusion, Doximity Inc (DOCS) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
